Press release
Investigation announced for Investors in NASDAQ: AMRN shares over potential Violations of Securities Laws by Amarin Corporation plc
An investigation for investors in Amarin Corporation plc (NASDAQ: AMRN) shares over potential securities laws violations.
Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Amarin Corporation plc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Ireland based Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. On August 8, 2019, Amarin Corporation plc announced that it received notice from the FDA that it plans to hold an advisory committee meeting, tentatively scheduled for November 14, 2019, in connection with its review of the pending supplemental new drug application for expansion of Vascepa. Amarin Corporation plc stated that the FDA's deadline for making an approval decision on Vascepa would likely be extended.
Just one week earlier, on July 31, 2019, Amarin Corporation plc said it was unlikely that the FDA would proceed with an advisory panel review regarding approval of Vascepa and anticipated a September 28, 2019 approval.
Shares of Amarin Corporation plc (NASDAQ: AMRN) declined to as low as $13.76 per share on August 12, 2019.
Those who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in NASDAQ: AMRN shares over potential Violations of Securities Laws by Amarin Corporation plc here
News-ID: 1822653 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Amarin
Omega 3 Prescription Drugs Market Estimated to Reach USD 2.63 Billion by 2030 | …
The latest report by Congruence Market Insights, titled 'Global Omega 3 Prescription Drugs Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2023 - 2030,' presents a comprehensive analysis of the global omega 3 prescription drugs market. This report meticulously examines both macro and micro trends, providing insights into factors influencing the market dynamics. It delves into qualitative and quantitative aspects, presenting a precise depiction of market size,…
Omega 3 Prescription Drug Market Outlook Highlights Major Opportunities by 2030 …
Omega 3 Prescription Drug Market Report research report is a wide-ranging analysis of and in the global market and in-detail information with segmentation has been added in this intelligence report. In this report, a comprehensive analysis of the current global Global Omega 3 Prescription Drug Market market in terms of demand and supply environment is provided, as well as price trends currently and in the next few years.
Global leading players…
Amarin Corporation plc (NASDAQ: AMRN) Investor Notice: Investigation of potentia …
An investigation on behalf of investors in shares of Amarin Corporation plc (NASDAQ: AMRN) concerning potential breaches of fiduciary duties by certain directors and officers of Amarin Corporation plc was announced.
Investors who are current long term investors in Amarin Corporation plc (NASDAQ: AMRN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in…
Deadline coming up in Lawsuit filed for Investors in shares of Amarin Corporatio …
A deadline is coming up on December 23, 2021 in the lawsuit filed for certain investors of Amarin Corporation plc (NASDAQ: AMRN) over alleged securities laws violations by Amarin Corporation plc.
Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and there are strict and short deadlines running. Deadline: December 23, 2021. (NASDAQ: AMRN)stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According…
Lawsuit filed for Investors in shares of Amarin Corporation plc (NASDAQ: AMRN)
An investor, who purchased shares of Amarin Corporation plc (NASDAQ: AMRN), filed a lawsuit in the over alleged violations of Federal Securities Laws by Amarin Corporation plc.
Investors who purchased shares of Amarin Corporation plc (NASDAQ: AMRN) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2021. NASDAQ: AMRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Ireland based…
Neurodegenerative Diseases Market by 2021-2025 | Pfizer, Bayer, AstraZeneca, Nov …
The Reports Web Analysts Forecasts the latest report on “Global Neurodegenerative Diseases Market Impact and Analysis by 2025”, according to report; The Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth.
Get Sample PDF Report Here:
https://www.reportsweb.com/inquiry&RW00014399065/sample?utm_source=opr&utm_medium=10300
Market Scenario:
It studies different models that address the challenges faced by several industries as well as stakeholders. This Neurodegenerative Diseases market is…
